More FDA Plan B fallout. “A consultant to a Food and Drug Administration advisory panel has resigned in protest of the agency’s handling of the Plan B contraceptive.
Dr. Frank Davidoff, editor emeritus of the Annals of Internal Medicine, said the agency is ignoring science in favor of politics in delaying approval of the drug for over-the-counter sales.”
